Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lithium orotate is a salt composed of lithium and orotic acid. It is primarily marketed as an over-the-counter dietary supplement and promoted for use as a low-dose source of lithium. Unlike prescription forms such as lithium carbonate and citrate, which are used in the treatment of bipolar disorder and other psychiatric conditions, clinical evidence supporting the efficacy of lithium orotate is limited. Some noncontrolled studies have explored its use for alcoholism, migraines, depression associated with bipolar disorder, ADHD in children and teens with emotional dysregulation, and other mood disorders[1][2][3]. Mechanistically, it is proposed that the compound may cross the blood–brain barrier more efficiently than other forms of lithium salts[4][5]. However, robust clinical data are lacking to confirm these claims. Lithium acts by modulating neurotransmitter activity in the brain—primarily through inhibition of inositol monophosphatase—which affects signal transduction pathways involved in mood regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lithium orotate.